A nurse is caring for a client who has leukemia. The nurse understands that this condition is characterized by what type of neoplasia?

Choice A reason:

This is a correct answer because healing of ulcers is an expected outcome of PPI therapy for PUD, as it occurs when the acid-induced damage to the mucosa is repaired and the ulcer is closed.

Choice B reason:

This is a correct answer because relief of pain is an expected outcome of PPI therapy for PUD, as it occurs when the acid-induced irritation and inflammation of the mucosa and the nerve endings are reduced.

Choice C reason:

This is an incorrect answer because eradication of H. pylori is not an expected outcome of PPI therapy for PUD, as it requires a combination of antibiotics and bismuth compounds to kill the bacteria and prevent its recurrence.

Choice D reason:

This is a correct answer because prevention of bleeding is an expected outcome of PPI therapy for PUD, as it occurs when the acid-induced erosion and perforation of the mucosa and the blood vessels are prevented.

Choice E reason:

This is a correct answer because reduction of inflammation is an expected outcome of PPI therapy for PUD, as it occurs when the acid-induced activation of inflammatory mediators and immune cells are inhibited.

Choice A reason:

Type I hypersensitivity is not involved in RA, as it does not involve IgE antibodies or mast cells.

Choice B reason:

Type II hypersensitivity is not involved in RA, as it does not involve IgG or IgM antibodies or target cells.2

Choice C reason:

RA is caused by type III hypersensitivity, which involves the formation and deposition of immune complexes in the synovial membranes of the joints. This triggers complement activation, inflammation, and tissue damage.

Choice D reason:

Type IV hypersensitivity is not involved in RA, as it does not involve cytotoxic T cells or helper T cells.